全文获取类型
收费全文 | 273921篇 |
免费 | 22264篇 |
国内免费 | 8570篇 |
专业分类
耳鼻咽喉 | 1266篇 |
儿科学 | 8809篇 |
妇产科学 | 1970篇 |
基础医学 | 22704篇 |
口腔科学 | 3688篇 |
临床医学 | 31029篇 |
内科学 | 77298篇 |
皮肤病学 | 2783篇 |
神经病学 | 26488篇 |
特种医学 | 8280篇 |
外国民族医学 | 4篇 |
外科学 | 20968篇 |
综合类 | 40740篇 |
现状与发展 | 33篇 |
一般理论 | 11篇 |
预防医学 | 18671篇 |
眼科学 | 2357篇 |
药学 | 20876篇 |
215篇 | |
中国医学 | 12769篇 |
肿瘤学 | 3796篇 |
出版年
2024年 | 269篇 |
2023年 | 5180篇 |
2022年 | 6890篇 |
2021年 | 13016篇 |
2020年 | 13192篇 |
2019年 | 10324篇 |
2018年 | 10239篇 |
2017年 | 10001篇 |
2016年 | 10184篇 |
2015年 | 10099篇 |
2014年 | 19526篇 |
2013年 | 21085篇 |
2012年 | 16014篇 |
2011年 | 17483篇 |
2010年 | 13741篇 |
2009年 | 13253篇 |
2008年 | 13321篇 |
2007年 | 13223篇 |
2006年 | 11659篇 |
2005年 | 9921篇 |
2004年 | 8328篇 |
2003年 | 7254篇 |
2002年 | 6129篇 |
2001年 | 5444篇 |
2000年 | 4393篇 |
1999年 | 3776篇 |
1998年 | 3330篇 |
1997年 | 2944篇 |
1996年 | 2529篇 |
1995年 | 2606篇 |
1994年 | 2420篇 |
1993年 | 2061篇 |
1992年 | 1936篇 |
1991年 | 1718篇 |
1990年 | 1379篇 |
1989年 | 1226篇 |
1988年 | 1133篇 |
1987年 | 1022篇 |
1986年 | 887篇 |
1985年 | 1062篇 |
1984年 | 890篇 |
1983年 | 535篇 |
1982年 | 642篇 |
1981年 | 555篇 |
1980年 | 425篇 |
1979年 | 358篇 |
1978年 | 291篇 |
1977年 | 253篇 |
1976年 | 220篇 |
1975年 | 113篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
66.
67.
68.
《Archivos de bronconeumología》2022,58(1):11-21
BackgroundWe aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment.MethodsMulticentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared. Primary outcome: COPD exacerbations. Secondary outcomes: side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication.ResultsOf 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1 = 43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (?33.3%; P < .001), hospital admissions (?33.3%; P < .001) and hospitalization days (?26.2%; P = .003). We found no difference in effectiveness between patients with or without associated bronchiectasis. Positive patient outcomes were more pronounced in PA-eradicated patients. We found a significant reduction in daily expectoration (?33.1%; P = .024), mucopurulent/purulent sputum (?53.9%; P < .001), isolation of any potentially pathogenic microorganisms (PPM) (?16.7%; P < .001), CBI by any PPM (?37.4%; P < .001) and CBI by PA (?49.8%; P < .001). CBI by any PPM and ≥three previous exacerbations were associated with a better treatment response. 25.4% of patients presented non-severe side-effects, the most frequent of these being bronchospasm (10.5%), dyspnoea (8.8%) and cough (1.7%).ConclusionsIn COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis. 相似文献
69.
70.
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface. 相似文献